Page last updated: 2024-09-03

dermorphin, arg(2)- and tyrosyl-arginyl-phenylalanyl-lysinamide

dermorphin, arg(2)- has been researched along with tyrosyl-arginyl-phenylalanyl-lysinamide in 1 studies

Compound Research Comparison

Studies
(dermorphin, arg(2)-)
Trials
(dermorphin, arg(2)-)
Recent Studies (post-2010)
(dermorphin, arg(2)-)
Studies
(tyrosyl-arginyl-phenylalanyl-lysinamide)
Trials
(tyrosyl-arginyl-phenylalanyl-lysinamide)
Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-lysinamide)
120174017

Protein Interaction Comparison

ProteinTaxonomydermorphin, arg(2)- (IC50)tyrosyl-arginyl-phenylalanyl-lysinamide (IC50)
Mu-type opioid receptorMus musculus (house mouse)0.781
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.254

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Imam, MZ; Kong, D; Kuo, A; Smith, MT; Williams, CM1

Other Studies

1 other study(ies) available for dermorphin, arg(2)- and tyrosyl-arginyl-phenylalanyl-lysinamide

ArticleYear
Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources.
    Journal of medicinal chemistry, 2022, 02-10, Volume: 65, Issue:3

    Topics: Analgesics, Opioid; Animals; Biological Products; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Discovery; Humans; Ligands; Pain; Peptides; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

2022